Bioactive Compounds
-
BA1550 InhA-IN-2Summary: InhA-IN-2 is a Mycobacterium tuberculosis (enoyl ACP reductase) inhibitor. -
N2462 (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside -
BA3556 Lacto-N-neotetraoseSummary: Lacto-N-neotetraose (LNnT) is an endogenous metabolite.
-
BA1549 5-Geranoxy-7-methoxycoumarinSummary: 5-Geranoxy-7-methoxycoumarin is a coumarin with anticancer, antifungal and antibacterial activities.
-
BA3554 AQX-016ASummary: AQX-016A is an orally effective agonist.
-
BA3552 LinvoseltamabSummary: Linvoseltamab is a bispecific antibody that targets and epsilon.
-
BA1547 SpirolaxineSummary: Spirolaxine is a plant growth inhibitor with significant anti-Helicobacter pylori activity.
-
N2456 Palmitic acid3 CitationSummary: A long-chain saturated fatty acid -
BA3551 SR-318Summary: SR-318 is a potent and highly selective inhibitor of p38α, and p38α/β at 5 nM, 32 nM, and 6.11 μM, respectively.
-
N2453 EpiberberineSummary: BACE1 inhibitor